Category: Healthcare and Pharmaceutical

Treadmill-Themed Deal Toy

Treadmill-themed deal toy recognizing a growth recapitalization by Great Point Partners of Spine & Sport Physical Therapy. Spine & Sport provides physical therapy and rehabilitation services through 16 outpatient clinics in the San Diego area.

(9AMF013)
1 Image

Hospital Private Placement Tombstone

Crystal tombstone commemorating a private placement by the Cleveland Clinic, a London hospital.

(8AKL767)
1 Image

Office Building-Themed Lucite Tombstone

Custom Lucite tombstone celebrating a strategic partnership between private equity firm Corsair Capital and Spring Venture Group. Based in Kansas City, Spring Venture Group is a provider of Medicare supplement insurance.

(8AJH292)
1 Image

Vitamin-Themed Deal Toy

Custom crystal deal toy marking the acquisition by Nestle Foods of organic vitamin company Garden of Life.

(9AMF019)
1 Image

Medical Technology Deal Tombstone

Crystal deal tombstone recognizing the acquisition of Munich, Germany-based Humediq. The company’s technology aids radiation therapy by providing patient management information.

(8ALJ480)
1 Image

Biopharmaceutical Funding Tombstone

Custom crystal tombstone celebrating a second close of Series A financing for Fusion Pharmaceuticals. The Hamilton, Ontario-based firm is focused on radiotherapeutics for treating cancer.

(8ALJ479)
1 Image

Logo-Themed Private Placement Tombstone

Custom crystal tombstone marking a private placement by Swiss biopharmaceutical company Auris Medical. Ladenburg Thalmann acted as exclusive placement agent.

(8AMF064)
1 Image

Pyramid-Shaped Deal Toy

Pyramid-shaped deal toy commemorating convertible notes issued by Ligand Pharmaceuticals, based in San Diego. Goldman Sachs and Barclays acted as Joint Book-Running Managers for the issue.

(8ALJ247)
1 Image

Crystal Commemorative for Drug Research Collaboration

Custom crystal commemorating a research collaboration involving Neurocrine Biosciences and Jnana Therapeutics. The research centers on finding new small-molecule therapeutics targeting central nervous system disorders.

(8ALJ498)
1 Image